Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TSLA vs MRNA✓SelectedUSD · MRNATSLA vs MRNA performance historyLatest closeAs of-2.43%11/19
Stock and ETF performance explorer

TSLA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-1.2%
MRNA return
-24.9%
Excess return
+23.7%
Maximum drawdown
-73.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.4%+1.3%-3.7%-2.6%
7D-5.8%-13.8%+8.0%-4.4%
30D+0.2%-17.7%+17.8%+1.8%
3M+6.6%+14.3%-7.7%+4.1%
6M-7.3%+336.0%-343.3%-30.2%
YTD-16.7%+575.9%-592.7%-44.1%
1Y-7.3%+724.4%-731.7%-40.8%
3Y+59.8%+160.8%-101.0%+21.0%
5Y-1.2%-24.4%+23.2%-14.3%
All-1.2%-24.9%+23.7%-14.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling